Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01370746 · ClinicalTrials.gov registry record
Perceived Barriers to Patient Adherence After Pediatric Solid Organ Transplantation
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 502
- Enrollment target
NCT01370746: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT01370746 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 502 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01370746 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 502 participants
- Enrollment target
Study Summary
In this study, doctors will observe how and when pediatric patients who have received a solid organ transplant take their prescribed medication, and determining if there are reasons that keep these patients from taking all of their medicine.
Primary Outcome
Barriers assessed using Brief Medication Questionnaire (BMQ); Adolescent Medication Barrier Scales questionnaire (AMBS); and Parent Medication Barriers Scale questionnaire (PMBS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 502 participants |
| Start Date | 2012-04 |
| Est. Completion | 2014-04 |
What the finished NCT01370746 record still lists
NCT01370746 is an observational study that tracks outcomes without assigning an intervention. The registered 502 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01370746 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01370746 about?
NCT01370746 is a clinical study titled "Perceived Barriers to Patient Adherence After Pediatric Solid Organ Transplantation". In this study, doctors will observe how and when pediatric patients who have received a solid organ transplant take their prescribed medication, and determining if there are reasons that keep these patients from taking all of their medicine.
What is the current status of trial NCT01370746?
This trial is currently completed. The enrollment target is 502 participants. The study started on 2012-04. Estimated completion is 2014-04.
Who is sponsoring clinical trial NCT01370746?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05646381 · 502 participants · Phase 2
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
- NCT05897632 · 502 participants · NA
CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)
- NCT05143931 · 503 participants · NA
Avoid and Resist Strategies for Weight Management
- NCT04442022 · 501 participants · Phase 2
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia